comparemela.com

Roche Alecensa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC

With this approval, alectinib is the first anaplastic lymphoma kinase inhibitor to be approved for patients with ALK-positive, early-stage non-small cell lung cancer.

Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Roche taps AI to find cancer patients after trial success

Roche’s lung cancer drug scored a win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to AI to find patients.

Roche Taps AI to Find Lung Cancer Patients After Trial Success

Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificial intelligence to find patients who can benefit.

Roche Taps AI To Find Cancer Patients After Trial Success

Roche Taps AI To Find Cancer Patients After Trial Success
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.